Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Postmenopausal Women: early-phase trial registry
A small indexed set (5 trials) with no open enrollment listed right now.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · none currently recruiting · #3,391 of 28,707 conditions by registered trial count
Postmenopausal Women: 5 US clinical trials tracked, none currently recruiting.
Postmenopausal Women is the subject of 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Warner Chilcott, running 1 of these trials.
Enrollment posture brief
Registry condition postmenopausal-women
OPEN 0 | RECR 0% | LATE 0 | EARLY 3 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Postmenopausal Women has no open enrollment in this registry pull (5 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Postmenopausal Women on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Postmenopausal Women is recruiting below its size-band peers.
0 of 5 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Postmenopausal Women research.
Warner Chilcott accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Postmenopausal Women trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.
-
Postmenopausal Women research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Tocotrienols for Obesity of Postmenopausal Women
Texas Tech University Health Sciences Center
NCT03705845
Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate
Warner Chilcott
NCT00577720
Soy Nuts and Cardiovascular Risk in Postmenopausal Women
Beth Israel Deaconess Medical Center
NCT01740076
Vitamin D Deficiency: Bone Loss and Vascular Dysfunction
University of Kansas
NCT00235586
Postmenopausal Women and Their Endothelium
Penn State University
NCT03644472
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Postmenopausal Women records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Postmenopausal Women trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Postmenopausal Women page
5 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Postmenopausal Women trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Warner Chilcott sponsors the most Postmenopausal Women trials on record, review their full trial history before evaluating a specific study. See Warner Chilcott's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Postmenopausal Women condition card totals 5 registered trials; most-linked intervention 10 vit. D deficient subjects take vit. D for 3 months.; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.